Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CIEN vs GSK✓SelectedUSD · GSKCIEN vs GSK performance historyLatest closeAs of+0.66%11/18
Stock and ETF performance explorer

CIEN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.5%
GSK return
+7.0%
Excess return
+35.6%
Maximum drawdown
-63.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.0%+0.3%
7D-10.0%-3.1%-6.8%-10.6%
30D-22.6%-0.9%-21.7%-22.4%
3M-34.3%-4.2%-30.1%-33.5%
6M-49.2%-1.6%-47.6%-49.2%
YTD+14.0%+2.6%+11.4%+11.7%
1Y+42.5%+6.2%+36.3%+37.5%
All+42.5%+7.0%+35.6%+37.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling